The sum was factored into the company’s sales and earnings outlook for the year, he said. Meanwhile, Pfizer expanded its ...

Pfizer will continue operating in Lee County after consolidating facilities. The move comes 18 months after Pfizer confirmed ...

Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...

Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...

The company’s CEO said he’s had “productive discussions” with Trump administration officials on a recently launched trade ...

After years of falling Covid treatment sales, lukewarm drug launches and a fizzled out weight-loss play, Pfizer is focusing on cost-cutting and reinvesting in new drug research in hopes that it ...

Pfizer said today it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research operations and reported lower first-quarter revenue due to declining sales of its ...

Pfizer Q1 EPS beat at $0.92 vs. $0.67 estimate, but sales dipped 8% YoY to $13.71 billion, below $13.95 billion forecast. Paxlovid sales plunged 75%, while Vyndaqel jumped 33% and Comirnaty rose ...

(Reuters) -Pfizer said on ... LEANING ON COST SAVINGS The company said it now expects about $7.7 billion in savings by the end of 2027 from its cost-cutting programs. That includes an additional ...

Pfizer on Tuesday reaffirmed its outlook for ... The company launched its multiyear cost-cutting plan in 2023 after the drugmaker miscalculated demand for its Covid-19 products.